• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26929
Device Problems Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/13/2019
Event Type  Injury  
Event Description
It was reported that stent elongation occurred resulting in patient surgery.An innova (5x120x130cm) self expanding stent was selected for treatment in a lower extremity peripheral angiogram procedure.The innova stent was placed in the distal right superficial femoral artery (sfa) without any noted resistance during deployment.The physician used the pull grip to complete the deployment process and started to retract the stent delivery system back on the 0.035 guidewire and through the 6f non-bsc sheath.The innova stent was observed to be stretched when the device was retracted through the 6f non-bsc sheath which was located in the in the left common femoral artery (cfa) extending into the proximal right sfa.The stent delivery system was fully removed from that patient.The 0.035 guidewire remained in place through the entire right sfa.It appeared that 40mm of the stent was deployed normally in the distal sfa before the stent began to stretch back ending with the proximal end of the stent being 80mm in the sheath.The physician estimated that the stent stretched about 300mm its entirety.The physician was not able to get the stent out of the sheath.The patient was in stable condition.The physician elected to take the patient to surgery.The outcome and the patient's condition post surgery was unknown at the time of reporting.
 
Manufacturer Narrative
Updated information to b3 date of event.It was originally reported that the event date was (b)(6) 2019 however through additional information on the medwatch report the event date was corrected to (b)(6) 2019.
 
Event Description
It was reported that stent elongation occurred resulting in patient surgery.An innova (5x120x130cm) self expanding stent was selected for treatment in a lower extremity peripheral angiogram procedure.The innova stent was placed in the distal right superficial femoral artery (sfa) without any noted resistance during deployment.The physician used the pull grip to complete the deployment process and started to retract the stent delivery system back on the 0.035 guidewire and through the 6f non-bsc sheath.The innova stent was observed to be stretched when the device was retracted through the 6f non-bsc sheath which was located in the in the left common femoral artery (cfa) extending into the proximal right sfa.The stent delivery system was fully removed from that patient.The 0.035 guidewire remained in place through the entire right sfa.It appeared that 40mm of the stent was deployed normally in the distal sfa before the stent began to stretch back ending with the proximal end of the stent being 80mm in the sheath.The physician estimated that the stent stretched about 300mm its entirety.The physician was not able to get the stent out of the sheath.The patient was in stable condition.The physician elected to take the patient to surgery.The outcome and the patient's condition post surgery was unknown at the time of reporting.It was further reported via voluntary medwatch mw5089127 that the stent deployed into the distal end of the sheath due to a delivery system malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA VASCULAR
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8962221
MDR Text Key156797796
Report Number2134265-2019-10554
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08714729873945
UDI-Public08714729873945
Combination Product (y/n)N
PMA/PMN Number
P140028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/14/2021
Device Model Number26929
Device Catalogue Number26929
Device Lot Number0022792154
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/14/2019
Initial Date FDA Received09/04/2019
Supplement Dates Manufacturer Received09/03/2019
Supplement Dates FDA Received09/06/2019
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-